1-6 of 6
Greg Koval
Close
Sort by
Journal Articles

Comparison Of Deep Sequencing and Allele-Specific Oligonucleotide PCR Methods For MRD Quantitation In Acute Lymphoblastic Leukemia and Mantle Cell Lymphoma: CALGB 10403 and CALGB 59909 (Alliance)

Greg Malnassy, MS, Susan Geyer, PhD, Noreen Fulton, B.S., Greg Koval, B.S., Donna Niedzwiecki, PhD, Victoria Carlton, PhD, Li Weng, PhD, Lawrence D. Kaplan, MD, Guido Marcucci, MD, Lloyd E Damon, MD, Richard A. Larson, MD, Richard M. Stone, MD, Bruce D. Cheson, M.D., Malek Faham, MD, PhD, Wendy Stock, M.D.
Journal: Blood
Blood (2013) 122 (21): 2547.
https://doi.org/10.1182/blood.V122.21.2547.2547
Published: 2013
Journal Articles

Minimal Residual Disease (MRD) Status Following Induction Chemo-Immunotherapy Predicts Progression-Free Survival In Mantle Cell Lymphoma (MCL): CALGB 50403 (Alliance)

Noreen Fulton, B.S., Jeffrey Johnson, M.S., Lawrence D. Kaplan, M.D., Greg Koval, B.S., Greg Malnassy, B.S., Sin-Ho Jung, Ph.D., Steve Devine, M.D., Thomas C. Shea, M.D., John P. Leonard, M.D., Bruce D. Cheson, M.D., Wendy Stock, M.D.
Journal: Blood
Blood (2013) 122 (21): 3002.
https://doi.org/10.1182/blood.V122.21.3002.3002
Published: 2013
Journal Articles

Treatment-influenced associations of PML-RAR α mutations, FLT3 mutations, and additional chromosome abnormalities in relapsed acute promyelocytic leukemia

Robert E. Gallagher, Barry K. Moser, Janis Racevskis, Xavier Poiré, Clara D. Bloomfield, Andrew J. Carroll, Rhett P. Ketterling, Diane Roulston, Esther Schachter-Tokarz, Da-cheng Zhou, I-Ming L. Chen, Richard Harvey, Greg Koval, Dorie A. Sher, James H. Feusner, Martin S. Tallman, Richard A. Larson, Bayard L. Powell, Frederick R. Appelbaum, Elisabeth Paietta, Cheryl L. Willman, Wendy Stock
Journal: Blood
Blood (2012) 120 (10): 2098–2108.
https://doi.org/10.1182/blood-2012-01-407601
Published: 2012
Includes: Supplemental data
Journal Articles

Clonal Markers In Relapsed Acute Promyelocytic Leukemia (APL): Clinicopathological Associations and Relation to All-Trans Retinoic Acid (ATRA) Treatment on Intergroup Phase III Trial C9710.

Robert E. Gallagher, MD, Barry K. Moser, PhD, Janis Racevskis, Xavier Poiré, MD, Clara D. Bloomfield, MD, Andrew J. Carroll, PhD, Rhett Ketterling, Diane Ralston, Esther Schachter-Tokarz, Dacheng Zhou, MD, PhD, I-Ming L. Chen, DVM, MS, Richard Harvey, Greg Koval, MS, Dorie A Sher, BS, James H. Feusner, MD, Martin S. Tallman, MD, Frederick R. Appelbaum, MD, Richard A. Larson, MD, Bayard L. Powell, MD, Elisabeth Paietta, PhD, Cheryl L. Willman, MD, Wendy Stock, MD
Journal: Blood
Blood (2010) 116 (21): 1038.
https://doi.org/10.1182/blood.V116.21.1038.1038
Published: 2010
Journal Articles

Mimetic Peptide to CDK Inhibitor p16 INK4a Induces Cell Death In Mantle Cell Lymphoma Cells: A New Strategy to Eradicate Minimal Residual Disease

Hongtao Liu, MD, PhD, Greg Koval, MS, Greg Malnassy, MS, Pamela Ihonor, MS, Hui Liu, MS, Roger Luo, PhD, Amittha Wickrema, PhD, Steven Dowdy, PhD, Michael Thirman, MD, Koen van Besien, MD, Wendy Stock, MD
Journal: Blood
Blood (2010) 116 (21): 3921.
https://doi.org/10.1182/blood.V116.21.3921.3921
Published: 2010
Journal Articles

Combination of a MEK Inhibitor, AZD6244, and Dual PI3K/mTOR Inhibitor, NVP-BEZ235: An Effective Therapeutic Strategy for Acute Myeloid Leukemia

Hongtao Liu, MD, PhD, Ernesto Diaz-Flores, PhD, Xavier Poiré, MD, Olatoyosi Odenike, MD, Greg Koval, MS, Greg Malnassy, MS, Pamela Ihonor, MS, Yanming Zhang, MD, Michelle M. Le Beau, PhD, Kevin Shannon, MD, Wendy Stock, MD
Journal: Blood
Blood (2010) 116 (21): 3978.
https://doi.org/10.1182/blood.V116.21.3978.3978
Published: 2010